Advanced genetic sequencing for cancer patients would now become more affordable and easily accessible, with the newly announced collaboration between GenepoweRx, India’s most trusted Genetic Testing company, and Onco.com, India’s leading patient-centric cancer care management platform. These two well-known names in their industries have agreed to work together in carrying out advanced cancer genomics test and reporting accurate recommendations specific to the Indian population towards targeted therapy in cancer.
As per WHO 2020 report, 1 in 10 Indians will develop cancer in their lifetime and 1 in 15 will die of the disease. Average survival after the diagnosis improved significantly after the advent of targeted therapies. The targeted therapy is an advanced and new form of cancer treatment which focuses on the root causes i.e. genetic changes or mutations that turn healthy cells into cancer cells. There are over 82 FDA approved targeted therapy drugs covering more than 15 types of cancers, including those of the breast, prostate, colon, and lung; these targeted therapies work precisely if the tumour has the right target. To use targeted therapy, the oncologist recommends genetic tests to understand the genetic changes responsible for cancer cell growth. With the growing incidents of cancer in India and the rising need of onco-gene specific genetic testing specific to the Indian population, this collaboration is the much-needed hope for the cancer Onco.com is India’s leading patient-centric cancer care management platform offering end-to-end support to cancer patients and their family having PAN-India presence with 1500+ oncologists and 500+ treatment centers consisting of hospitals, clinics, and onco cancer centers.